FederalMD
Posted
Sep 18, 2026
Sep 28, 2026
Nimh: Procurement of Assay Kits *SOLE SOURCE*
Single-Cell Multiome ATAC + GEM gene expression sequencing assay kits.
Description: The National Institutes of Health Office of Logistics and Acquisition Operations is soliciting Single-Cell Multiome ATAC + Gene Expression Sequencing Assay kits from 10X Genomics, Inc. to support research into chromatin epigenetics, ketamine-response biomarkers, and genome-wide regulatory profiles in human samples and cerebral organoids. The procurement includes RNase inhibitor, indexing kits, Chromium Next GEM Multiome reagent bundles and chip kits, with delivery expected within 10 calendar days after award. Offerors must provide pricing, shipping and handling costs, delivery terms and period, product details, entity identifiers, and business-size certification.
Federal · MD, US
Original attachments and procurement documents tied to this bid.
Federal RFP files are for Starbridge customers only.
You can request RFP files from all other buyer types for free on this site.
Decision makers connected to this RFP from National Institutes of Health OLAO.
Adjacent opportunities open for bidding right now.
FederalMD
Posted
Sep 18, 2026
Sep 28, 2026
Single-Cell Multiome ATAC + GEM gene expression sequencing assay kits.
FederalMD
Posted
Sep 18, 2026
Sep 28, 2026
Procure brand name or equivalent specialized high density active electrodes and matching electronics.
National Institutes of Health OLAO
FederalMD
Posted
Sep 18, 2026
Sep 28, 2026
This active Combined Synopsis/Solicitation is a contract procurement issued by NIMH for diagnostic laboratory equipment, not a grant program. The equipment is intended for ongoing studies examining activity across a very large number of single neurons, ranging from hundreds to thousands. Responses are due September 28, 2026, and the notice identifies the contracting office in Bethesda, Maryland.
FederalMD
Posted
Sep 15, 2026
Sep 25, 2026
Procure histology services to complete the neuropathological characterization of donors older than 50 years of age to ensure that donors classified as neurotypical controls are indeed free of degenerative neuropathology.